PURCHASE AGREEMENTPurchase Agreement • March 6th, 2019 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Illinois
THIS PURCHASE AGREEMENT (the “Agreement”), dated as of March 4, 2019 (the “Execution Date”), is entered into by and between IDERA PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”). Capitalized terms used herein and not otherwise defined herein are defined in Section 1 hereof.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 6th, 2019 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Illinois
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 4, 2019, is entered into by and between IDERA PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with its permitted assigns, the “Investor”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
